On February 1, the action of a part of the simplifications that were introduced under the notification regime in drugs are completed.
Jarmoluk / Pixabay.
From February 1, the rule "15 minutes" is canceled - when you could move the medication 15 minutes after submitting information into the system. Until July 1, there is still simplification for acceptance of drugs. For pharmacies and hospitals, nothing changes - they give data to the system and can immediately sell or use medicines. This is provided for by the Government Decree of 1779 of 2.11.2020.
"We see an increase in the competencies of the industry when working with labeled drugs. If we compare with October, the number of errors decreased by 2 times, and the technical support appeals in the last two weeks of January - one and a half - twice compared with the first weeks of November. And hospitals and pharmacies still prefer standard schemes: the notification regime in January of the hospital was used in 0.3% of cases, pharmacies - less than 3%. For its part, the operator has increased the performance of the system, the documents are processed on average for 7-8 minutes, "said Egor Zhavoronov, head of the Pharma's commodity group.
Over the past three months, a situational center has been created, the work of the client service is reformatted, the typical errors of the turnover participants are analyzed to minimize them, interaction with AIS of Roszdravnadzor is modified when entering drugs in turnover (allows you to accelerate the input of drugs into circulation). The leading companies conducted an experiment on strict traceability, and from January 25, load testing is available for pharmaceutically.
"The notification procedure for the work of the marking system, introduced by the Government at the beginning of November, undoubtedly made his contribution - he allowed a number of serious technical issues and allowed unloading the system, which ultimately contributed to the increase in the stability of the work of the SMDLP. Together with other market participants, we are conducting an open and constructive dialogue with CRPT on all arising issues, including access to analytical data for each pack. Getting this information will give manufacturers the ability to track the entire supply chain of real-time drugs for more efficient planning, as well as monitoring patient requests to the manufacturer on quality issues. In addition, we believe that in the medium term it is important to discuss the need to schema 702/703, since their application does not allow full use of data on the side of the manufacturers, thus devaluating one of the main tasks of the marking system - ensuring traceability of drugs and access to data. We hope that the exit from the notification order from February 1 will not affect the efficiency of the labeling system and the possibility of ensuring the smooth movement of goods in the commander-conducting chain, "says Yana Kotukhov, director of working with state authorities and external communications on the EAEE Countries of Servier .
Marking: What is important to know now?
Retail.ru.